Landmark Bio™ Appoints Gregg Nyberg, Ph.D., as Chief Technology Officer and Michael Covington as Chief Quality and Regulatory Office

The Boston Globe: Harvard-MIT’s Landmark Bio hires California executive as CEO

Harvard Magazine: Landmark Bio Breaks Ground

The Harvard Gazette: Veteran biotech executive to run new center aimed at boosting cell and gene therapies

Introducing Landmark Bio and Appointment of Ran Zheng as CEO

Worcester Business Journal: Cytiva named as founding member of Watertown biomanufacturing facility.

The Harvard Gazette: Big step forward for planned center to boost cell- and gene-therapy advances

The Harvard Crimson: Center for Advanced Biological Innovation and Manufacturing Secures $76 Million in Funding, Signs Lease

CommonWealth: Consortium plans to build cell manufacturing facility.

STAT: Facing bottlenecks in manufacturing cell therapies, Boston leaders plan to build their own